NAMSA, a world leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, has announced its agreement to acquire ÅKRN Scientific Consulting, a prominent European Medical Device CRO based in Madrid, Spain.
ÅKRN, founded in 2018, focuses on providing exceptional services to the medical device and diagnostic industries in Europe. Grounded in medicine and science, the organization assists Sponsors move MedTech products from medical discovery into clinical development, commercialization and Post-Market Follow-Up. Known for their expertise in Cardiovascular research, ÅKRN’s Team of Clinical Scientists and Project Managers serve as trusted Client Advisors throughout the complete clinical development process via diligent planning and superior execution.
“We are thrilled to welcome ÅKRN to NAMSA,” said Dr. Christophe Berthoux, CEO of NAMSA. “The organization is well-respected for their proficiency in European medical device regulations and providing exceptional clinical support to MedTech Sponsors. Adding them to our team will expand our depth of expertise, enabling us to meet the growing demand for safe, efficient clinical development and commercialization of life-changing medical products,” Dr. Berthoux concluded.
The team in charge of the operation was led by Bestax managing partner Igor Alonso, together with partner and head of the firm´s Commercial department Mario Aurelio Peña, Commercial lawyer Pablo Foncea, and Financial advisor Nora Martínez.
